Literature DB >> 12113456

Inducible, reversible hair loss in transgenic mice.

Jingshan Chen1, Max B Kelz, Guoqi Zeng, Cathy Steffen, Penny E Shockett, Gordon Terwilliger, David G Schatz, Eric J Nestler.   

Abstract

Telogen effluvium is a common type of hair loss. Although the morphological changes associated with telogen effluvium have been well characterized, the underlying molecular mechanisms remain unknown, and no animal models have been developed. We report here that inducible transgenic mice expressing high levels of the transcription factor, tTA (tetracycline transactivator), plus a reporter luciferase gene, show a reversible hair loss phenotype. Skin of these mice exhibits an increase in the number of hair follicles at the telogen phase, but a decreased number of follicles at the anagen phase. These changes resemble skin pathology seen in patients with telogen effluvium, which suggests that the inducible transgenic mice may be useful as a model for this disorder. Moreover, since overexpression of several other transgenes failed to cause skin pathology, the present findings also indicate types of molecular abnormalities that may cause reversible hair loss.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12113456     DOI: 10.1023/a:1015619604318

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  22 in total

1.  Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

Authors:  A Yamamoto; J J Lucas; R Hen
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

2.  Pathologic dynamics of human hair loss. I. Telogen effuvium.

Authors:  A M KLIGMAN
Journal:  Arch Dermatol       Date:  1961-02

3.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

4.  Abnormal contraction caused by expression of G(i)-coupled receptor in transgenic model of dilated cardiomyopathy.

Authors:  A J Baker; C H Redfern; M D Harwood; P C Simpson; B R Conklin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-04       Impact factor: 4.733

5.  Chronic telogen effluvium.

Authors:  D A Whiting
Journal:  Dermatol Clin       Date:  1996-10       Impact factor: 3.478

6.  p53 Involvement in the control of murine hair follicle regression.

Authors:  V A Botchkarev; E A Komarova; F Siebenhaar; N V Botchkareva; A A Sharov; P G Komarov; M Maurer; A V Gudkov; B A Gilchrest
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

Review 7.  Telogen effluvium.

Authors:  A Rebora
Journal:  Dermatology       Date:  1997       Impact factor: 5.366

8.  DeltaFosB-induced cataract.

Authors:  M B Kelz; J R Kuszak; Y Yang; W Ma; C Steffen; K Al-Ghoul; Y J Zhang; J Chen; E J Nestler; A Spector
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

9.  The mRNA for protease nexin-1 is expressed in human dermal papilla cells and its level is affected by androgen.

Authors:  T Sonoda; Y Asada; S Kurata; S Takayasu
Journal:  J Invest Dermatol       Date:  1999-09       Impact factor: 8.551

10.  Neonatal tumor necrosis factor alpha promotes diabetes in nonobese diabetic mice by CD154-independent antigen presentation to CD8(+) T cells.

Authors:  E A Green; F S Wong; K Eshima; C Mora; R A Flavell
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

View more
  1 in total

Review 1.  Resting no more: re-defining telogen, the maintenance stage of the hair growth cycle.

Authors:  Mikhail Geyfman; Maksim V Plikus; Elsa Treffeisen; Bogi Andersen; Ralf Paus
Journal:  Biol Rev Camb Philos Soc       Date:  2014-11-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.